Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Urokinase Market Research Report 2025

Global Urokinase Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 79 Pages

Report ld: 3472190

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Urokinase Research：CAGR of 4.7% during the forecast period

Urokinase Market Size(US$)

CAGR 2025-2031

5.2%

Market Size,2031

USD 70.6

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 52.1 million

Market Forecast in 2031(Value)

US$ 70.6 million

CAGR

5.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urokinase.

The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urokinase market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Syner-Med

Wanhua Biochem

Jiangxi Haoran Bio-Pharma

Jiangsu Aidea Pharmaceutical

Techpool

Microbic Biosystems

LIVZON

Segment by Type

Urokinase Powder

Urokinase Solution

Segment by Application

Hospital

Clinic

Others

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Urokinase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Urokinase Market Overview

1.1 Product Definition

1.2 Urokinase by Type

1.2.1 Global Urokinase Market Value Comparison by Type (2024 VS 2031)

1.2.2 Urokinase Powder

1.2.3 Urokinase Solution

1.3 Urokinase by Application

1.3.1 Global Urokinase Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Urokinase Market Size Estimates and Forecasts

1.4.1 Global Urokinase Revenue 2020-2031

1.4.2 Global Urokinase Sales 2020-2031

1.4.3 Global Urokinase Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Urokinase Market Competition by Manufacturers

2.1 Global Urokinase Sales Market Share by Manufacturers (2020-2025)

2.2 Global Urokinase Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Urokinase Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Urokinase, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Urokinase, Product Type & Application

2.7 Global Key Manufacturers of Urokinase, Date of Enter into This Industry

2.8 Global Urokinase Market Competitive Situation and Trends

2.8.1 Global Urokinase Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Urokinase Players Market Share by Revenue

2.8.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Urokinase Market Scenario by Region

3.1 Global Urokinase Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Urokinase Sales by Region: 2020-2031

3.2.1 Global Urokinase Sales by Region: 2020-2025

3.2.2 Global Urokinase Sales by Region: 2026-2031

3.3 Global Urokinase Revenue by Region: 2020-2031

3.3.1 Global Urokinase Revenue by Region: 2020-2025

3.3.2 Global Urokinase Revenue by Region: 2026-2031

3.4 North America Urokinase Market Facts & Figures by Country

3.4.1 North America Urokinase Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Urokinase Sales by Country (2020-2031)

3.4.3 North America Urokinase Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Urokinase Market Facts & Figures by Country

3.5.1 Europe Urokinase Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Urokinase Sales by Country (2020-2031)

3.5.3 Europe Urokinase Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Urokinase Market Facts & Figures by Region

3.6.1 Asia Pacific Urokinase Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Urokinase Sales by Region (2020-2031)

3.6.3 Asia Pacific Urokinase Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Urokinase Market Facts & Figures by Country

3.7.1 Latin America Urokinase Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Urokinase Sales by Country (2020-2031)

3.7.3 Latin America Urokinase Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Urokinase Market Facts & Figures by Country

3.8.1 Middle East and Africa Urokinase Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Urokinase Sales by Country (2020-2031)

3.8.3 Middle East and Africa Urokinase Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Urokinase Sales by Type (2020-2031)

4.1.1 Global Urokinase Sales by Type (2020-2025)

4.1.2 Global Urokinase Sales by Type (2026-2031)

4.1.3 Global Urokinase Sales Market Share by Type (2020-2031)

4.2 Global Urokinase Revenue by Type (2020-2031)

4.2.1 Global Urokinase Revenue by Type (2020-2025)

4.2.2 Global Urokinase Revenue by Type (2026-2031)

4.2.3 Global Urokinase Revenue Market Share by Type (2020-2031)

4.3 Global Urokinase Price by Type (2020-2031)

5 Segment by Application

5.1 Global Urokinase Sales by Application (2020-2031)

5.1.1 Global Urokinase Sales by Application (2020-2025)

5.1.2 Global Urokinase Sales by Application (2026-2031)

5.1.3 Global Urokinase Sales Market Share by Application (2020-2031)

5.2 Global Urokinase Revenue by Application (2020-2031)

5.2.1 Global Urokinase Revenue by Application (2020-2025)

5.2.2 Global Urokinase Revenue by Application (2026-2031)

5.2.3 Global Urokinase Revenue Market Share by Application (2020-2031)

5.3 Global Urokinase Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Syner-Med

6.1.1 Syner-Med Company Information

6.1.2 Syner-Med Description and Business Overview

6.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Syner-Med Urokinase Product Portfolio

6.1.5 Syner-Med Recent Developments/Updates

6.2 Wanhua Biochem

6.2.1 Wanhua Biochem Company Information

6.2.2 Wanhua Biochem Description and Business Overview

6.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Wanhua Biochem Urokinase Product Portfolio

6.2.5 Wanhua Biochem Recent Developments/Updates

6.3 Jiangxi Haoran Bio-Pharma

6.3.1 Jiangxi Haoran Bio-Pharma Company Information

6.3.2 Jiangxi Haoran Bio-Pharma Description and Business Overview

6.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Jiangxi Haoran Bio-Pharma Urokinase Product Portfolio

6.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates

6.4 Jiangsu Aidea Pharmaceutical

6.4.1 Jiangsu Aidea Pharmaceutical Company Information

6.4.2 Jiangsu Aidea Pharmaceutical Description and Business Overview

6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Jiangsu Aidea Pharmaceutical Urokinase Product Portfolio

6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates

6.5 Techpool

6.5.1 Techpool Company Information

6.5.2 Techpool Description and Business Overview

6.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Techpool Urokinase Product Portfolio

6.5.5 Techpool Recent Developments/Updates

6.6 Microbic Biosystems

6.6.1 Microbic Biosystems Company Information

6.6.2 Microbic Biosystems Description and Business Overview

6.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Microbic Biosystems Urokinase Product Portfolio

6.6.5 Microbic Biosystems Recent Developments/Updates

6.7 LIVZON

6.7.1 LIVZON Company Information

6.7.2 LIVZON Description and Business Overview

6.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2020-2025)

6.7.4 LIVZON Urokinase Product Portfolio

6.7.5 LIVZON Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Urokinase Industry Chain Analysis

7.2 Urokinase Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Urokinase Production Mode & Process Analysis

7.4 Urokinase Sales and Marketing

7.4.1 Urokinase Sales Channels

7.4.2 Urokinase Distributors

7.5 Urokinase Customer Analysis

8 Urokinase Market Dynamics

8.1 Urokinase Industry Trends

8.2 Urokinase Market Drivers

8.3 Urokinase Market Challenges

8.4 Urokinase Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Urokinase Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Urokinase Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Urokinase Market Competitive Situation by Manufacturers in 2024

Table 4. Global Urokinase Sales (BIU) of Key Manufacturers (2020-2025)

Table 5. Global Urokinase Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Urokinase Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Urokinase Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Urokinase Average Price (US$/MIU) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Urokinase, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Urokinase, Product Type & Application

Table 12. Global Key Manufacturers of Urokinase, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Urokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urokinase as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Urokinase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Urokinase Sales by Region (2020-2025) & (BIU)

Table 18. Global Urokinase Sales Market Share by Region (2020-2025)

Table 19. Global Urokinase Sales by Region (2026-2031) & (BIU)

Table 20. Global Urokinase Sales Market Share by Region (2026-2031)

Table 21. Global Urokinase Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Urokinase Revenue Market Share by Region (2020-2025)

Table 23. Global Urokinase Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Urokinase Revenue Market Share by Region (2026-2031)

Table 25. North America Urokinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Urokinase Sales by Country (2020-2025) & (BIU)

Table 27. North America Urokinase Sales by Country (2026-2031) & (BIU)

Table 28. North America Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Urokinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Urokinase Sales by Country (2020-2025) & (BIU)

Table 32. Europe Urokinase Sales by Country (2026-2031) & (BIU)

Table 33. Europe Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Urokinase Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Urokinase Sales by Region (2020-2025) & (BIU)

Table 37. Asia Pacific Urokinase Sales by Region (2026-2031) & (BIU)

Table 38. Asia Pacific Urokinase Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Urokinase Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Urokinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Urokinase Sales by Country (2020-2025) & (BIU)

Table 42. Latin America Urokinase Sales by Country (2026-2031) & (BIU)

Table 43. Latin America Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Urokinase Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Urokinase Sales by Country (2020-2025) & (BIU)

Table 47. Middle East and Africa Urokinase Sales by Country (2026-2031) & (BIU)

Table 48. Middle East and Africa Urokinase Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Urokinase Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Urokinase Sales (BIU) by Type (2020-2025)

Table 51. Global Urokinase Sales (BIU) by Type (2026-2031)

Table 52. Global Urokinase Sales Market Share by Type (2020-2025)

Table 53. Global Urokinase Sales Market Share by Type (2026-2031)

Table 54. Global Urokinase Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Urokinase Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Urokinase Revenue Market Share by Type (2020-2025)

Table 57. Global Urokinase Revenue Market Share by Type (2026-2031)

Table 58. Global Urokinase Price (US$/MIU) by Type (2020-2025)

Table 59. Global Urokinase Price (US$/MIU) by Type (2026-2031)

Table 60. Global Urokinase Sales (BIU) by Application (2020-2025)

Table 61. Global Urokinase Sales (BIU) by Application (2026-2031)

Table 62. Global Urokinase Sales Market Share by Application (2020-2025)

Table 63. Global Urokinase Sales Market Share by Application (2026-2031)

Table 64. Global Urokinase Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Urokinase Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Urokinase Revenue Market Share by Application (2020-2025)

Table 67. Global Urokinase Revenue Market Share by Application (2026-2031)

Table 68. Global Urokinase Price (US$/MIU) by Application (2020-2025)

Table 69. Global Urokinase Price (US$/MIU) by Application (2026-2031)

Table 70. Syner-Med Company Information

Table 71. Syner-Med Description and Business Overview

Table 72. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 73. Syner-Med Urokinase Product

Table 74. Syner-Med Recent Developments/Updates

Table 75. Wanhua Biochem Company Information

Table 76. Wanhua Biochem Description and Business Overview

Table 77. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 78. Wanhua Biochem Urokinase Product

Table 79. Wanhua Biochem Recent Developments/Updates

Table 80. Jiangxi Haoran Bio-Pharma Company Information

Table 81. Jiangxi Haoran Bio-Pharma Description and Business Overview

Table 82. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 83. Jiangxi Haoran Bio-Pharma Urokinase Product

Table 84. Jiangxi Haoran Bio-Pharma Recent Developments/Updates

Table 85. Jiangsu Aidea Pharmaceutical Company Information

Table 86. Jiangsu Aidea Pharmaceutical Description and Business Overview

Table 87. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 88. Jiangsu Aidea Pharmaceutical Urokinase Product

Table 89. Jiangsu Aidea Pharmaceutical Recent Developments/Updates

Table 90. Techpool Company Information

Table 91. Techpool Description and Business Overview

Table 92. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 93. Techpool Urokinase Product

Table 94. Techpool Recent Developments/Updates

Table 95. Microbic Biosystems Company Information

Table 96. Microbic Biosystems Description and Business Overview

Table 97. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 98. Microbic Biosystems Urokinase Product

Table 99. Microbic Biosystems Recent Developments/Updates

Table 100. LIVZON Company Information

Table 101. LIVZON Description and Business Overview

Table 102. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2020-2025)

Table 103. LIVZON Urokinase Product

Table 104. LIVZON Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Urokinase Distributors List

Table 108. Urokinase Customers List

Table 109. Urokinase Market Trends

Table 110. Urokinase Market Drivers

Table 111. Urokinase Market Challenges

Table 112. Urokinase Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Urokinase

Figure 2. Global Urokinase Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Urokinase Market Share by Type: 2024 & 2031

Figure 4. Urokinase Powder Product Picture

Figure 5. Urokinase Solution Product Picture

Figure 6. Global Urokinase Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Urokinase Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Urokinase Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Urokinase Market Size (2020-2031) & (US$ Million)

Figure 13. Global Urokinase Sales (2020-2031) & (BIU)

Figure 14. Global Urokinase Average Price (US$/MIU) & (2020-2031)

Figure 15. Urokinase Report Years Considered

Figure 16. Urokinase Sales Share by Manufacturers in 2024

Figure 17. Global Urokinase Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Urokinase Players: Market Share by Revenue in Urokinase in 2024

Figure 19. Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Urokinase Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Urokinase Sales Market Share by Country (2020-2031)

Figure 22. North America Urokinase Revenue Market Share by Country (2020-2031)

Figure 23. United States Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Urokinase Sales Market Share by Country (2020-2031)

Figure 26. Europe Urokinase Revenue Market Share by Country (2020-2031)

Figure 27. Germany Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Urokinase Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Urokinase Revenue Market Share by Region (2020-2031)

Figure 34. China Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Urokinase Sales Market Share by Country (2020-2031)

Figure 44. Latin America Urokinase Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Urokinase Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Urokinase Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Urokinase Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Urokinase by Type (2020-2031)

Figure 54. Global Revenue Market Share of Urokinase by Type (2020-2031)

Figure 55. Global Urokinase Price (US$/MIU) by Type (2020-2031)

Figure 56. Global Sales Market Share of Urokinase by Application (2020-2031)

Figure 57. Global Revenue Market Share of Urokinase by Application (2020-2031)

Figure 58. Global Urokinase Price (US$/MIU) by Application (2020-2031)

Figure 59. Urokinase Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Urokinase in 2025? zhanKai

The global market size of Urokinase in 2025 was 52.1 Million USD.

What is the annual compound growth rate of the global Urokinase market size from 2025 to 2031? shouQi

What was the global market size of Urokinase in 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Urokinase market? shouQi

Related Reports

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)

Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)